Table 3.

Correlation between plasma concentration of the adipocytokines and the body mass index, and carbohydrate-lipid metabolism parameters in obese patients with type 2 diabetes before the implementation of insulin therapy and after 6-month treatment.

Parameters	Obese Patients with Type 2 Diabetes Mellitus Before the Implementation of Insulin Therapy
	Omentin-1 (ng/mL)	NGAL (ng/mL)	CTRP3 (ng/mL)
BMI (kg/m2)	−0.060 NS	−0.114 NS	0.137 NS
Glucose (mg/dL)	0.135 NS	−0.345 (p = 0.032)	−0.058 NS
HbA1c (%)	0.158 NS	−0.016 NS	−0.129 NS
Cholesterol (mg/dL)	0.140 NS	−0.020 NS	−0.305 (p = 0.048)
HDL (mg/dL)	−0.092 NS	−0.211 NS	−0.229 NS
LDL (mg/dL)	0.145 NS	0.039 NS	−0.345 (p = 0.033)
Triglycerides (mg/dL)	−0.076 NS	−0.019 NS	−0.015 NS
NGAL (ng/mL)	0.029 NS
CTRP3 (ng/mL)	0.354 (p = 0.024)	0.04 NS
	Obese Patients with Type 2 Diabetes Mellitus After the 6-Month Insulin Treatment
	Omentin-1(ng/mL)	NGAL (ng/mL)	CTRP3 (ng/mL)
BMI (kg/m2)	0.021 NS	−0.083 NS	0.073 NS
Glucose (mg/dL)	0.200 NS	−0.082 NS	0.033 NS
HbA1c (%)	0.358 (p = 0.025)	0.082 NS	−0.192 NS
Cholesterol (mg/dL)	0.030 NS	0.072 NS	0.032 NS
HDL (mg/dL)	−0.072 NS	−0.396 (p = 0.041)	−0.021 NS
LDL (mg/dL)	0.096 NS	0.175 NS	−0.069 NS
Triglycerides (mg/dL)	−0.055 NS	0.107 NS	−0.262 NS
NGAL (ng/mL)	−0.003 NS
CTRP3 (ng/mL)	0.16 NS	−0.25 NS